Since the approval of three hydroxamic acid-based HDAC inhibitors as anticancer drugs, such functional groups acquired even more notoriety in synthetic medicinal chemistry. The ability of hydroxamic acids (HAs) to chelate metal ions makes this moiety an attractive metal binding group - in particular, Fe(III) and Zn(II) - so that HA derivatives find wide applications as metalloenzymes inhibitors. In this minireview, we will discuss the most relevant features concerning hydroxamic acid derivatives. In a first instance, the physicochemical characteristics of HAs will be summarized; then, an exhaustive description of the most relevant methods for the introduction of such moiety into organic substrates and an overview of their uses in medicinal chemistry will be presented.

Hydroxamic Acid Derivatives: From Synthetic Strategies to Medicinal Chemistry Applications / Citarella, A.; Moi, D.; Pinzi, L.; Bonanni, D.; Rastelli, G.. - In: ACS OMEGA. - ISSN 2470-1343. - 6:34(2021), pp. 21843-21849. [10.1021/acsomega.1c03628]

Hydroxamic Acid Derivatives: From Synthetic Strategies to Medicinal Chemistry Applications

Citarella A.;Moi D.;Pinzi L.;Rastelli G.
2021

Abstract

Since the approval of three hydroxamic acid-based HDAC inhibitors as anticancer drugs, such functional groups acquired even more notoriety in synthetic medicinal chemistry. The ability of hydroxamic acids (HAs) to chelate metal ions makes this moiety an attractive metal binding group - in particular, Fe(III) and Zn(II) - so that HA derivatives find wide applications as metalloenzymes inhibitors. In this minireview, we will discuss the most relevant features concerning hydroxamic acid derivatives. In a first instance, the physicochemical characteristics of HAs will be summarized; then, an exhaustive description of the most relevant methods for the introduction of such moiety into organic substrates and an overview of their uses in medicinal chemistry will be presented.
2021
20-ago-2021
6
34
21843
21849
Hydroxamic Acid Derivatives: From Synthetic Strategies to Medicinal Chemistry Applications / Citarella, A.; Moi, D.; Pinzi, L.; Bonanni, D.; Rastelli, G.. - In: ACS OMEGA. - ISSN 2470-1343. - 6:34(2021), pp. 21843-21849. [10.1021/acsomega.1c03628]
Citarella, A.; Moi, D.; Pinzi, L.; Bonanni, D.; Rastelli, G.
File in questo prodotto:
File Dimensione Formato  
acsomega.1c03628.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 3.44 MB
Formato Adobe PDF
3.44 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1257607
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 39
  • ???jsp.display-item.citation.isi??? 36
social impact